Thermo Fisher Scientific Inc. (TMO) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Thermo Fisher Scientific Inc. (TMO) Bundle
Evaluate the financial prospects of Thermo Fisher Scientific Inc. (TMO) like an expert! This (TMO) DCF Calculator provides you with pre-filled financials while allowing you the freedom to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25,542.0 | 32,218.0 | 39,211.0 | 44,915.0 | 42,857.0 | 49,050.6 | 56,139.4 | 64,252.6 | 73,538.3 | 84,166.0 |
| Revenue Growth, % | 0 | 26.14 | 21.71 | 14.55 | -4.58 | 14.45 | 14.45 | 14.45 | 14.45 | 14.45 |
| EBITDA | 6,463.0 | 10,192.0 | 12,964.0 | 11,941.0 | 11,195.0 | 13,999.8 | 16,023.0 | 18,338.7 | 20,988.9 | 24,022.2 |
| EBITDA, % | 25.3 | 31.63 | 33.06 | 26.59 | 26.12 | 28.54 | 28.54 | 28.54 | 28.54 | 28.54 |
| Depreciation | 2,277.0 | 2,325.0 | 2,592.0 | 3,381.0 | 3,406.0 | 3,749.1 | 4,290.9 | 4,911.0 | 5,620.8 | 6,433.1 |
| Depreciation, % | 8.91 | 7.22 | 6.61 | 7.53 | 7.95 | 7.64 | 7.64 | 7.64 | 7.64 | 7.64 |
| EBIT | 4,186.0 | 7,867.0 | 10,372.0 | 8,560.0 | 7,789.0 | 10,250.7 | 11,732.1 | 13,427.6 | 15,368.2 | 17,589.2 |
| EBIT, % | 16.39 | 24.42 | 26.45 | 19.06 | 18.17 | 20.9 | 20.9 | 20.9 | 20.9 | 20.9 |
| Total Cash | 2,399.0 | 10,325.0 | 4,477.0 | 8,524.0 | 8,077.0 | 8,896.0 | 10,181.6 | 11,653.1 | 13,337.2 | 15,264.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4,952.0 | 6,472.0 | 8,945.0 | 9,427.0 | 9,664.0 | 10,381.7 | 11,882.0 | 13,599.2 | 15,564.6 | 17,813.9 |
| Account Receivables, % | 19.39 | 20.09 | 22.81 | 20.99 | 22.55 | 21.17 | 21.17 | 21.17 | 21.17 | 21.17 |
| Inventories | 3,370.0 | 4,029.0 | 5,051.0 | 5,634.0 | 5,088.0 | 6,180.1 | 7,073.2 | 8,095.4 | 9,265.3 | 10,604.4 |
| Inventories, % | 13.19 | 12.51 | 12.88 | 12.54 | 11.87 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 |
| Accounts Payable | 1,920.0 | 2,175.0 | 2,867.0 | 3,381.0 | 2,872.0 | 3,512.9 | 4,020.5 | 4,601.6 | 5,266.6 | 6,027.7 |
| Accounts Payable, % | 7.52 | 6.75 | 7.31 | 7.53 | 6.7 | 7.16 | 7.16 | 7.16 | 7.16 | 7.16 |
| Capital Expenditure | -926.0 | -1,474.0 | -2,523.0 | -2,243.0 | -1,479.0 | -2,264.2 | -2,591.4 | -2,965.9 | -3,394.5 | -3,885.1 |
| Capital Expenditure, % | -3.63 | -4.58 | -6.43 | -4.99 | -3.45 | -4.62 | -4.62 | -4.62 | -4.62 | -4.62 |
| Tax Rate, % | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 |
| EBITAT | 3,801.3 | 6,941.5 | 9,062.7 | 7,593.1 | 7,414.3 | 9,232.1 | 10,566.3 | 12,093.4 | 13,841.1 | 15,841.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1,249.7 | 5,868.5 | 6,328.7 | 8,180.1 | 9,141.3 | 9,548.2 | 10,380.1 | 11,880.2 | 13,597.1 | 15,562.1 |
| WACC, % | 7.58 | 7.57 | 7.56 | 7.57 | 7.61 | 7.58 | 7.58 | 7.58 | 7.58 | 7.58 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 48,340.4 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 16,185 | |||||||||
| Terminal Value | 452,390 | |||||||||
| Present Terminal Value | 313,982 | |||||||||
| Enterprise Value | 362,322 | |||||||||
| Net Debt | 26,840 | |||||||||
| Equity Value | 335,482 | |||||||||
| Diluted Shares Outstanding, MM | 388 | |||||||||
| Equity Value Per Share | 864.64 |
What You Will Get
- Comprehensive TMO Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Instant Calculations: Intrinsic value and NPV are dynamically computed for your convenience.
- Scenario Analysis: Evaluate various scenarios to assess Thermo Fisher's future performance.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Thermo Fisher Scientific Inc. (TMO).
- WACC Calculator: Pre-designed Weighted Average Cost of Capital sheet with adjustable inputs specific to the needs of Thermo Fisher.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Thermo Fisher's financial outlook.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Thermo Fisher Scientific Inc. (TMO).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Thermo Fisher Scientific's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and utilize the results for your investment decisions.
Why Choose This Calculator for Thermo Fisher Scientific Inc. (TMO)?
- Precision: Utilizes accurate financial data from Thermo Fisher to ensure reliability.
- Adaptability: Crafted to allow users to easily adjust and experiment with inputs.
- Efficiency: Eliminate the need to create a DCF model from the ground up.
- Expert-Level: Designed with the expertise and usability expected by CFOs.
- Intuitive: Simple to navigate, making it accessible for users without deep financial modeling skills.
Who Should Use This Product?
- Life Science Researchers: Utilize advanced tools to analyze experimental data and enhance research outcomes.
- Healthcare Professionals: Integrate cutting-edge technologies into clinical practices for improved patient care.
- Pharmaceutical Companies: Streamline drug development processes and optimize research strategies with real-time analytics.
- Laboratory Technicians: Enhance laboratory efficiency with customizable workflows and automated solutions.
- Academic Institutions: Incorporate innovative methodologies into teaching and research programs.
What the Template Contains
- Preloaded TMO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.